Nephrotic syndrome trials in Netherlands

2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

  Where

  Amsterdam

  Age

  16 years to 75 years

  People

  84 worldwide

  Run by

  Sanofi

  See details and how to joinNCT06500702
• Phase 2Taking people
  Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  Where

  Amsterdam, Nijmegen

  Age

  1 year to 17 years

  People

  67 worldwide

  Run by

  Travere Therapeutics, Inc.

  See details and how to joinNCT05003986 · EU 2023-505497-14-00